RECRUITING Phase 3 ClinicalTrials.gov

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Sponsor: Sanofi • ClinicalTrials.gov ID: NCT07190209

Registry updated: 2026-10-19

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in adult participants (aged 40 to 80 years, inclusive) with inadequately controlled Chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype. Participation to the study consists of 3 periods: * Screening period of up to 4 weeks * Randomized intervention period of approximately 48 weeks * Follow-up period: Approximately 8 weeks The study duration will be up to 60 weeks.

Interventions

Lunsekimig (Drug)
Pharmaceutical form: solution for injection in prefilled syringe. Route of administration: Subcutaneous injection
Placebo (Drug)
Pharmaceutical form: solution for injection. Route of administration: Subcutaneous injection

Eligibility criteria

Inclusion Criteria: * Between 40 to 80 years of age * Physician diagnosed chronic obstructive pulmonary disease (COPD) ≥1 year * Post-bronchodilator forced expiratory volume in 1 second (post-BD FEV1) ≥ 20% and ≤ 70% of predicted value and FEV1/FVC (forced expiratory volume in 1 second /forced vital capacity) \<0.70 * Former or current smokers ≥10 pack-years * Chronic Airways Assessment Test (CAAT) ≥10 * ≥2 moderate or ≥1 severe COPD exacerbations in the prior year * Triple (ICS+LABA+LAMA) COPD therapy ≥12 consecutive weeks * EOS (blood eosinophil count) ≥ 150 cells/μL * 18.0 ≤ Body Mass Index ≤ 40.0 kg/m2 Exclusion Criteria: Participants are excluded from the study if any of the following criteria apply: * Asthma, including pediatric asthma, or asthma-COPD overlap syndrome (ACOS) * Significant pulmonary disease other than COPD * Long-term oxygen therapy \>4.0 L/min or requirement of \>2.0 L/min to maintain oxygen saturation \>88% at rest * Unstable disorder that can impact participants safety or study outcomes * Active or incompletely treated tuberculosis * Current or past malignancies * Concomitant therapies: * long-term macrolides or phosphodiesterase Type 3 (PDE-3) or PDE-4 inhibitors unless on stable therapy for \>6 months * any biologic therapy or systemic immunosuppressant within 4 months or 5 half-lives prior to Screening The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial

Conditions

Chronic Obstructive Pulmonary Disease

Locations

Chandler Clinical Research Trials- Site Number : 8400025 — Chandler, Arizona, United States
Pulmonary Associates - Phoenix - East Bell Road- Site Number : 8400114 — Phoenix, Arizona, United States
Epic Medical Research - Surprise- Site Number : 8400096 — Surprise, Arizona, United States
IMAX Clinical Trials- Site Number : 8400109 — La Palma, California, United States
Long Beach Research Institute- Site Number : 8400027 — Long Beach, California, United States
Downtown L.A. Research Center- Site Number : 8400009 — Los Angeles, California, United States
Newport Native MD- Site Number : 8400003 — Newport Beach, California, United States
Paradigm Research - Redding- Site Number : 8400108 — Redding, California, United States
Amicis Research Center - Valencia- Site Number : 8400119 — Valencia, California, United States
Helix Biomedics- Site Number : 8400065 — Boynton Beach, Florida, United States
Beautiful Minds Clinical Research Center- Site Number : 8400017 — Cutler Bay, Florida, United States
Solution Clinical Research- Site Number : 8400039 — Doral, Florida, United States
Eastern Medical Group Research- Site Number : 8400020 — Fort Myers, Florida, United States
Premier Medical Associates- Site Number : 8400012 — Lady Lake, Florida, United States
University of Miami Dermatology Clinical Trials Unit- Site Number : 8400078 — Miami, Florida, United States
MCR Research- Site Number : 8400004 — Miami, Florida, United States
Nuren Medical & Research Center- Site Number : 8400030 — Miami, Florida, United States
My Community Research Center- Site Number : 8400164 — Miami, Florida, United States
Reed Medical Research Corp- Site Number : 8400167 — Miami, Florida, United States
Deluxe Health Center- Site Number : 8400010 — Miami Lakes, Florida, United States
Omega Research Consultants - Orlando - Forest City- Site Number : 8400015 — Orlando, Florida, United States
Pharmakon Medical Research- Site Number : 8400156 — Palm Beach Gardens, Florida, United States
Broward Research Center - Pembroke Pines- Site Number : 8400053 — Pembroke Pines, Florida, United States
Clinical Research Trials of Florida- Site Number : 8400011 — Tampa, Florida, United States
Deluxe Health Center-Tampa- Site Number : 8400056 — Tampa, Florida, United States
Private Practice - Dr. David Kavtaradze- Site Number : 8400006 — Cordele, Georgia, United States
Primeway Clinical Research- Site Number : 8400121 — Fayetteville, Georgia, United States
University of Illinois-Chicago - College of Medicine- Site Number : 8400055 — Chicago, Illinois, United States
Avicenna Clinical Research- Site Number : 8400126 — Chicago Ridge, Illinois, United States
NorthShore Medical Group - Evanston ( Endeavor Health)- Site Number : 8400073 — Evanston, Illinois, United States
Indy Clinical Research- Site Number : 8400071 — Indianapolis, Indiana, United States
University of Kansas Medical Center- Site Number : 8400054 — Kansas City, Kansas, United States
Southern Clinical Research - Zachary- Site Number : 8400113 — Zachary, Louisiana, United States
Brigham & Women's Hospital- Site Number : 8400148 — Boston, Massachusetts, United States
University of Michigan Health System - Ann Arbor- Site Number : 8400090 — Ann Arbor, Michigan, United States
Veritas Clinical Research- Site Number : 8400007 — Madison Heights, Michigan, United States
Mayo Clinic in Rochester - Minnesota- Site Number : 8400005 — Rochester, Minnesota, United States
Henderson Clinical Trials- Site Number : 8400026 — Henderson, Nevada, United States
Sanmora Bespoke Clinical Research Solutions- Site Number : 8400144 — East Orange, New Jersey, United States
New York Hospital Queens- Site Number : 8400058 — Flushing, New York, United States
Duke Asthma, Allergy and Airway Center- Site Number : 8400047 — Durham, North Carolina, United States
Advanced Respiratory and Sleep Medicine - Hickory- Site Number : 8400013 — Hickory, North Carolina, United States
Science 37, Llc- Site Number : 8400154 — Morrisville, North Carolina, United States
Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400048 — Winston-Salem, North Carolina, United States
Plains Clinical Research Center- Site Number : 8400140 — Fargo, North Dakota, United States
Dayton Clinical Research- Site Number : 8400124 — Dayton, Ohio, United States
Epic Medical Research - Chickasha- Site Number : 8400097 — Chickasha, Oklahoma, United States
Oregon Health & Science University (OHSU)- Site Number : 8400155 — Portland, Oregon, United States
Temple University Hospital- Site Number : 8400059 — Philadelphia, Pennsylvania, United States
Preferred Primary Care Physicians - Pleasant Hills- Site Number : 8400092 — Pittsburgh, Pennsylvania, United States
AnMed Oglesby Center- Site Number : 8400074 — Anderson, South Carolina, United States
MD First Research - Lancaster- Site Number : 8400102 — Lancaster, South Carolina, United States
Circle Clinical Research- Site Number : 8400139 — Sioux Falls, South Dakota, United States
Meharry Medical College- Site Number : 8400133 — Nashville, Tennessee, United States
Wellness Clinical Research - Allen- Site Number : 8400085 — Allen, Texas, United States
REX Clinical Trials - Beaumont- Site Number : 8400014 — Beaumont, Texas, United States
Novel Research - Bellaire- Site Number : 8400116 — Bellaire, Texas, United States
South Texas Medical Research Institute - TTS Research- Site Number : 8400018 — Boerne, Texas, United States
TEN20 Clinical Research - Carrollton- Site Number : 8400141 — Carrollton, Texas, United States
Corsicana Medical Research- Site Number : 8400134 — Corsicana, Texas, United States
Syri Research Center- Site Number : 8400069 — Cypress, Texas, United States
Texas Health Presbyterian Hospital Dallas- Site Number : 8400032 — Dallas, Texas, United States
Epic Medical Research - De Soto- Site Number : 8400095 — DeSoto, Texas, United States
Valley Institute of Research- Site Number : 8400118 — Harlingen, Texas, United States
Trio Clinical Trials- Site Number : 8400106 — Houston, Texas, United States
HDH Research, Inc.- Site Number : 8400104 — Houston, Texas, United States
Baylor College of Medicine- Site Number : 8400076 — Houston, Texas, United States
Gulf Coast Clinical Research - Houston- Site Number : 8400049 — Houston, Texas, United States
Lumi Research - Kingwood- Site Number : 8400120 — Kingwood, Texas, United States
Syri Research Center- Site Number : 8400136 — Kingwood, Texas, United States
Radiance Clinical Research - Lampasas - West Avenue East- Site Number : 8400063 — Lampasas, Texas, United States
Discovery Clinical Trials - San Antonio- Site Number : 8400031 — San Antonio, Texas, United States
Bandera Family Health Care - San Antonio- Site Number : 8400021 — San Antonio, Texas, United States
Element Research Group- Site Number : 8400115 — San Antonio, Texas, United States
Tidewater Physicians Multispecialty Group Clinical Research - Williamsburg- Site Number : 8400081 — Williamsburg, Virginia, United States
Investigational Site Number : 0320007 — La Plata, Buenos Aires, Argentina
Investigational Site Number : 0320008 — Lobos, Buenos Aires, Argentina
Investigational Site Number : 0320004 — Rosario, Santa Fe Province, Argentina
Investigational Site Number : 0320012 — Rosario, Santa Fe Province, Argentina
Investigational Site Number : 0320006 — San Miguel de Tucumán, Tucumán Province, Argentina
Investigational Site Number : 0320003 — San Miguel de Tucumán, Tucumán Province, Argentina
Investigational Site Number : 0320011 — Buenos Aires, Argentina
Investigational Site Number : 0320005 — Buenos Aires, Argentina
Investigational Site Number : 0320010 — Buenos Aires, Argentina
Investigational Site Number : 0320001 — Buenos Aires, Argentina
Investigational Site Number : 0320002 — Buenos Aires, Argentina
Investigational Site Number : 0320009 — Buenos Aires, Argentina
Investigational Site Number : 0560004 — Brussels, Belgium
Investigational Site Number : 0560005 — Edegem, Belgium
Investigational Site Number : 0560008 — Erpent, Belgium
Investigational Site Number : 0560001 — Leuven, Belgium
Investigational Site Number : 0560003 — Mechelen, Belgium
Investigational Site Number : 0560007 — Yvoir, Belgium
Chronos Pesquisa Clínica- Site Number : 0760012 — Brasília, Federal District, Brazil
CETI - Centro de Estudos em Terapias Inovadoras- Site Number : 0760013 — Curitiba, Paraná, Brazil
Hospital Universitário Onofre Lopes- Site Number : 0760016 — Natal, Rio Grande do Norte, Brazil
Instituto Ceos- Site Number : 0760005 — Porto Alegre, Rio Grande do Sul, Brazil
LMK Servicos Medicos- Site Number : 0760018 — Porto Alegre, Rio Grande do Sul, Brazil
Hospital São Lucas da PUCRS - Porto Alegre - Avenida Ipiranga- Site Number : 0760001 — Porto Alegre, Rio Grande do Sul, Brazil
Fundação Faculdade Regional de Medicina de São José do Rio Preto- Site Number : 0760011 — São José do Rio Preto, São Paulo, Brazil
Centro Internacional de Pesquisa Clínica (CIPES)- Site Number : 0760008 — São José dos Campos, São Paulo, Brazil
Hospital Copa D'Or- Site Number : 0760017 — Rio de Janeiro, Brazil
Hospital Beneficência Portuguesa de São Paulo- Site Number : 0760010 — São Paulo, Brazil
Investigational Site Number : 1240011 — Calgary, Alberta, Canada
Investigational Site Number : 1240015 — Vancouver, British Columbia, Canada
Investigational Site Number : 1240010 — Ajax, Ontario, Canada
Investigational Site Number : 1240004 — Guelph, Ontario, Canada
Investigational Site Number : 1240012 — Ottawa, Ontario, Canada
Investigational Site Number : 1240009 — Stoney Creek, Ontario, Canada
Investigational Site Number : 1240001 — Toronto, Ontario, Canada
Investigational Site Number : 1240002 — Waterloo, Ontario, Canada
Investigational Site Number : 1520002 — Valdivia, Los Ríos Region, Chile
Investigational Site Number : 1520006 — Talca, Maule Region, Chile
Investigational Site Number : 1520004 — Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520001 — Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520003 — Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520005 — Viña del Mar, Valparaiso, Chile
Investigational Site Number : 1560035 — Beijing, China
Investigational Site Number : 1560013 — Beijing, China
Investigational Site Number : 1560054 — Changchun, China
Investigational Site Number : 1560010 — Changsha, China
Investigational Site Number : 1560032 — Changsha, China
Investigational Site Number : 1560018 — Chengdu, China
Investigational Site Number : 1560004 — Chengdu, China
Investigational Site Number : 1560005 — Chengdu, China
Investigational Site Number : 1560062 — Foshan, China
Investigational Site Number : 1560021 — Guangzhou, China
Investigational Site Number : 1560001 — Guangzhou, China
Investigational Site Number : 1560030 — Hangzhou, China
Investigational Site Number : 1560024 — Harbin, China
Investigational Site Number : 1560012 — Hefei, China
Investigational Site Number : 1560046 — Heifei, China
Investigational Site Number : 1560006 — Hohhot, China
Investigational Site Number : 1560044 — Huizhou, China
Investigational Site Number : 1560026 — Jiaozuo, China
Investigational Site Number : 1560039 — Jinan, China
Investigational Site Number : 1560049 — Jinhua, China
Investigational Site Number : 1560056 — Jining, China
Investigational Site Number : 1560043 — Kunming, China
Investigational Site Number : 1560023 — Langfang, China
Investigational Site Number : 1560047 — Liaocheng, China
Investigational Site Number : 1560033 — Linhai, China
Investigational Site Number : 1560002 — Nanchang, China
Investigational Site Number : 1560003 — Nanchang, China
Investigational Site Number : 1560051 — Nanning, China
Investigational Site Number : 1560017 — Ningbo, China
Investigational Site Number : 1560031 — Pingxiang, China
Investigational Site Number : 1560007 — Shanghai, China
Investigational Site Number : 1560008 — Shanghai, China
Investigational Site Number : 1560036 — Shenyang, China
Investigational Site Number : 1560037 — Shenzhen, China
Investigational Site Number : 1560027 — Shihezi, China
Investigational Site Number : 1560022 — Taiyuan, China
Investigational Site Number : 1560034 — Taizhou, China
Investigational Site Number : 1560019 — Tianjin, China
Investigational Site Number : 1560016 — Ürümqi, China
Investigational Site Number : 1560029 — Wenzhou, China
Investigational Site Number : 1560025 — Wuhan, China
Investigational Site Number : 1560050 — Wuxi, China
Investigational Site Number : 1560052 — Xi'an, China
Investigational Site Number : 1560020 — Xiamen, China
Investigational Site Number : 1560011 — Xiangtan, China
Investigational Site Number : 1560058 — Xinxiang, China
Investigational Site Number : 1560040 — Xuzhou, China
Investigational Site Number : 1560041 — Yangzhou, China
Investigational Site Number : 1560060 — Yichang, China
Investigational Site Number : 1560053 — Yinchuan, China
Investigational Site Number : 1560059 — Zhanjiang, China
Investigational Site Number : 1560057 — Zhengzhou, China
Investigational Site Number : 1560048 — Zunyi, China
Investigational Site Number : 2080005 — Aalborg, Denmark
Investigational Site Number : 2080004 — Hvidovre, Denmark
Investigational Site Number : 2080001 — Næstved, Denmark
Investigational Site Number : 2080002 — Odense, Denmark
Investigational Site Number : 2080003 — Vejle, Denmark
Investigational Site Number : 2330003 — Tallinn, Estonia
Investigational Site Number : 2330001 — Tartu, Estonia
Investigational Site Number : 2460002 — Turku, Finland
Investigational Site Number : 2500012 — Brest, France
Investigational Site Number : 2500008 — La Tronche, France
Investigational Site Number : 2500006 — Le Mans, France
Investigational Site Number : 2500002 — Lyon, France
Investigational Site Number : 2500003 — Montpellier, France
Investigational Site Number : 2500004 — Pessac, France
Investigational Site Number : 2500001 — Pontoise, France
Investigational Site Number : 2500005 — Reims, France
Investigational Site Number : 2500009 — Suresnes, France
Investigational Site Number : 2500011 — Vandœuvre-lès-Nancy, France
Investigational Site Number : 2680004 — Kutaisi, Georgia
Investigational Site Number : 2680002 — Tbilisi, Georgia
Investigational Site Number : 2680001 — Tbilisi, Georgia
Investigational Site Number : 2680005 — Tbilisi, Georgia
Investigational Site Number : 2680006 — Tbilisi, Georgia
Investigational Site Number : 2680003 — Tbilisi, Georgia
Investigational Site Number : 2760006 — Ahrensburg, Germany
Investigational Site Number : 2760011 — Augsburg, Germany
Investigational Site Number : 2760002 — Bendorf, Germany
Investigational Site Number : 2760009 — Berlin, Germany
Investigational Site Number : 2760007 — Berlin, Germany
Investigational Site Number : 2760013 — Darmstadt, Germany
Investigational Site Number : 2760004 — Frankfurt, Germany
Investigational Site Number : 2760008 — Frankfurt, Germany
Investigational Site Number : 2760003 — Frankfurt am Main, Germany
Investigational Site Number : 2760012 — Hamburg, Germany
Investigational Site Number : 2760001 — Leipzig, Germany
Investigational Site Number : 2760010 — Lübeck, Germany
Investigational Site Number : 2760005 — Mainz, Germany
Investigational Site Number : 2760018 — Munich, Germany
Investigational Site Number : 3480006 — Debrecen, Hungary
Investigational Site Number : 3480005 — Edelény, Hungary
Investigational Site Number : 3480001 — Gödöllő, Hungary
Investigational Site Number : 3480011 — Gyöngyös, Hungary
Investigational Site Number : 3480004 — Hajdúnánás, Hungary
Investigational Site Number : 3480002 — Mosonmagyaróvár, Hungary
Investigational Site Number : 3480009 — Pécs, Hungary
Investigational Site Number : 3480003 — Püspökladány, Hungary
Investigational Site Number : 3800004 — Telese Terme, Benevento, Italy
Investigational Site Number : 3800013 — Cona, Ferrara, Italy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano Site Number : 3800001 — Milan, Lombardy, Italy
Investigational Site Number : 3800007 — Rozzano, Milano, Italy
Azienda Ospedale Università di Padova Site Number : 3800011 — Padova, Veneto, Italy
Investigational Site Number : 3800005 — Pavia, Italy
Investigational Site Number : 3800010 — Reggio Emilia, Italy
Investigational Site Number : 3800008 — Tradate (Va), Italy
Investigational Site Number : 3920042 — Kōnan, Aichi-ken, Japan
Investigational Site Number : 3920032 — Nagoya, Aichi-ken, Japan
Investigational Site Number : 3920057 — Toyota, Aichi-ken, Japan
Investigational Site Number : 3920047 — Matsuyama, Ehime, Japan
Investigational Site Number : 3920026 — Fukuoka, Fukuoka, Japan
Investigational Site Number : 3920058 — Iizuka, Fukuoka, Japan
Investigational Site Number : 3920006 — Kurume, Fukuoka, Japan
Investigational Site Number : 3920053 — Kure, Hiroshima, Japan
Investigational Site Number : 3920049 — Sapporo, Hokkaido, Japan
Investigational Site Number : 3920024 — Himeji-Shi, Hyōgo, Japan
Investigational Site Number : 3920009 — Kobe, Hyōgo, Japan
Investigational Site Number : 3920008 — Kita, Kagawa-ken, Japan
Investigational Site Number : 3920030 — Sakaidechō, Kagawa-ken, Japan
Investigational Site Number : 3920060 — Takamatsu, Kagawa-ken, Japan
Investigational Site Number : 3920040 — Kamakura, Kanagawa, Japan
Investigational Site Number : 3920051 — Kawasaki, Kanagawa, Japan
Investigational Site Number : 3920035 — Yokohama, Kanagawa, Japan
Investigational Site Number : 3920054 — Yokohama, Kanagawa, Japan
Investigational Site Number : 3920015 — Yokohama, Kanagawa, Japan
Investigational Site Number : 3920045 — Matsusaka, Mie-ken, Japan
Investigational Site Number : 3920005 — Sendai, Miyagi, Japan
Investigational Site Number : 3920001 — Kashihara, Nara, Japan
Investigational Site Number : 3920012 — Okayama, Okayama-ken, Japan
Investigational Site Number : 3920043 — Sakai, Osaka, Japan
Investigational Site Number : 3920020 — Ureshino-Shi, Saga-ken, Japan
Investigational Site Number : 3920046 — Fujieda, Shizuoka, Japan
Investigational Site Number : 3920033 — Hachiōji, Tokyo, Japan
Investigational Site Number : 3920062 — Yonezawa, Yamagata, Japan
Investigational Site Number : 3920003 — Ube, Yamaguchi, Japan
Investigational Site Number : 3920021 — Chiba, Japan
Investigational Site Number : 3920002 — Fukushima, Japan
Investigational Site Number : 3920029 — Hiroshima, Japan
Investigational Site Number : 3920039 — Kagoshima, Japan
Investigational Site Number : 3920059 — Kiyose, Japan
Investigational Site Number : 3920036 — Kumamoto, Japan
Investigational Site Number : 3920018 — Kumamoto, Japan
Investigational Site Number : 3920056 — Kyoto, Japan
Investigational Site Number : 3920004 — Osaka, Japan
Investigational Site Number : 3920007 — Saga, Japan
Investigational Site Number : 3920028 — Tokyo, Japan
Investigational Site Number : 3920017 — Tokyo, Japan
Investigational Site Number : 3920023 — Tokyo, Japan
Investigational Site Number : 4280001 — Daugavpils, Latvia
Investigational Site Number : 4280003 — Riga, Latvia
Investigational Site Number : 4280002 — Riga, Latvia
Investigational Site Number : 4840001 — Monterrey, Nuevo León, Mexico
Investigational Site Number : 4840009 — San Juan del Río, Querétaro, Mexico
Investigational Site Number : 4840008 — Durango, Mexico
Investigational Site Number : 4840004 — Mexico City, Mexico
Investigational Site Number : 4840003 — Veracruz, Mexico
Investigational Site Number : 6160002 — Wroclaw, Lower Silesian Voivodeship, Poland
Investigational Site Number : 6160006 — Piaseczno, Masovian Voivodeship, Poland
Investigational Site Number : 6160001 — Bialystok, Podlaskie Voivodeship, Poland
Investigational Site Number : 6160009 — Katowice, Silesian Voivodeship, Poland
Investigational Site Number : 6160010 — Elblag, Poland
Investigational Site Number : 6160003 — Katowice, Poland
Investigational Site Number : 6160004 — Sosnowiec, Poland
Investigational Site Number : 6200002 — Almada, Portugal
Investigational Site Number : 6200004 — Braga, Portugal
Investigational Site Number : 6200005 — Guimarães, Portugal
Investigational Site Number : 6200003 — Matosinhos Municipality, Portugal
Investigational Site Number : 6200001 — Porto, Portugal
Investigational Site Number : 6820003 — Jeddah, Saudi Arabia
Investigational Site Number : 6820001 — Riyadh, Saudi Arabia
Investigational Site Number : 6820002 — Riyadh, Saudi Arabia
Investigational Site Number : 7240003 — Málaga, Andalusia, Spain
Investigational Site Number : 7240001 — Mérida, Badajoz, Spain
Investigational Site Number : 7240007 — L'Hospitalet de Llobregat, Catalunya [Cataluña], Spain
Investigational Site Number : 7240008 — Jerez de la Frontera, Cádiz, Spain
Investigational Site Number : 7240005 — Cáceres, Extremadura, Spain
Investigational Site Number : 7240006 — Benalmádena, Málaga, Spain
Investigational Site Number : 7240004 — Palma, Spain
Investigational Site Number : 7240002 — Seville, Spain
Investigational Site Number : 7520002 — Solna, Sweden
Investigational Site Number : 7520004 — Umeå, Sweden
Investigational Site Number : 7920002 — Adana, Turkey (Türkiye)
Investigational Site Number : 7920006 — Ankara, Turkey (Türkiye)
Investigational Site Number : 7920003 — Ankara, Turkey (Türkiye)
Investigational Site Number : 7920004 — Gaziantep, Turkey (Türkiye)
Investigational Site Number : 7920005 — Istanbul, Turkey (Türkiye)
Investigational Site Number : 7920007 — Izmir, Turkey (Türkiye)
Investigational Site Number : 7920001 — Mersin, Turkey (Türkiye)
Investigational Site Number : 8260014 — Bristol, Bristol, City of, United Kingdom
Investigational Site Number : 8260015 — London, Hammersmith and Fulham, United Kingdom
Investigational Site Number : 8260003 — Leicester, Leicestershire, United Kingdom
Investigational Site Number : 8260009 — Harrow, London, City of, United Kingdom
Investigational Site Number : 8260031 — London, London, City of, United Kingdom
Investigational Site Number : 8260034 — Oxford, Oxfordshire, United Kingdom
Investigational Site Number : 8260032 — Worthing, West Sussex, United Kingdom
Investigational Site Number : 8260002 — Bradford, United Kingdom

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment